Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure
ClinicalTrials.gov study NCT04677439. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
ClinicalTrials.gov study NCT02712112. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.
ClinicalTrials.gov study NCT00149136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)
ClinicalTrials.gov study NCT01172548. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate
ClinicalTrials.gov study NCT00093639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
ClinicalTrials.gov study NCT03802084. IPD Sharing: NO. Countries: 1. Publications: 0.
PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
ClinicalTrials.gov study NCT00335868. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib
ClinicalTrials.gov study NCT04409223. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors
ClinicalTrials.gov study NCT00580281. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
ClinicalTrials.gov study NCT00428909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension
ClinicalTrials.gov study NCT01279473. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00045422. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors
ClinicalTrials.gov study NCT00940563. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct
ClinicalTrials.gov study NCT01153750. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST
ClinicalTrials.gov study NCT05970900. IPD Sharing: NO. Countries: 1. Publications: 0.
Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01083589. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome
ClinicalTrials.gov study NCT00171860. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
ClinicalTrials.gov study NCT00928525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib
ClinicalTrials.gov study NCT01562847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT00052494. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.